会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 142. 发明授权
    • Acyl phosphate salts and their use
    • 酰基磷酸盐及其用途
    • US4701285A
    • 1987-10-20
    • US793722
    • 1985-10-31
    • George M. WhitesidesDebbie C. CransRomas J. Kazlaukas
    • George M. WhitesidesDebbie C. CransRomas J. Kazlaukas
    • C07F9/09C07C153/00
    • C07F9/096
    • This invention consists of the production of a salt of acyl phosphate in an aqueous solution by a process which involves (1) acylation of phosphoric acid (H.sub.3 PO.sub.4) with an acid anhydride of the general formula RCOX, where R can be hydrogen or a lower alkyl or aryl group having from 1 to 10 carbon atoms, and X can be a leaving group of the general formula OR, OCOR, X or NR.sub.2, followed by (2a) extraction of acyl phosphate to water by treatment of the reaction mixture with an aqueous bicarbonate or hydroxide solution or other basic aqueous solution, if the reaction is carried out in non-aqueous solvent or (2b) in the case where water has been used as reaction solvent acidification with acid or acid form of a carbon exchange resin. After (3) extraction of residual carboxylic acid from the resulting acidic aqueous mixture using a solvent in which the acid is soluble but with which water does not mix, the remaining aqueous solution of acyl phosphate is (4) neutralized by addition of a base such as sodium or potassium hydroxide.
    • 本发明包括在水溶液中制备酰基磷酸盐的方法,该方法包括:(1)用通式RCOX的酸酐使磷酸(H 3 PO 4)酰化,其中R可以是氢或低级烷基 或具有1至10个碳原子的芳基,X可以是通式OR,OCOR,X或NR2的离去基团,然后(2a)通过用水溶液处理反应混合物(2a)将酰基磷酸酯提取到水中 碳酸氢盐或氢氧化物溶液或其他碱性水溶液,如果反应在非水溶剂中进行,或(2b)在使用水作为与酸或酸形式的碳交换树脂反应溶剂酸化的情况下。 (3)使用其中酸是可溶性但不与水混合的溶剂从所得酸性含水混合物中提取残余羧酸后,残留的酰基磷酸酯水溶液(4)通过加入碱中和 作为氢氧化钠或氢氧化钾。
    • 150. 发明申请
    • SYSTEMS AND METHODS FOR AMPLIFICATION AND PHAGE DISPLAY
    • 放大和污染显示的系统和方法
    • US20130210680A1
    • 2013-08-15
    • US13702603
    • 2011-06-10
    • Ratmir DerdaSindy K.Y. TangGeorge M. Whitesides
    • Ratmir DerdaSindy K.Y. TangGeorge M. Whitesides
    • C12N15/10
    • C12N15/1037C40B40/02C40B50/06
    • The present invention generally relates to amplification of biological entities, for example, for phage display. In one aspect, members of a library of biological entities are encapsulated in separate compartments (e.g., in separate microfluidic droplets) and amplified. As a specific example, by putting members of a phage display library into microfluidic droplets such that no droplet contains more than one member of the library, the library can be amplified without any substantial changes in growth rates or population distributions, or other artifacts created due to differences in growth rates or amplification between different members of the library. In some cases, the volume of the compartments can be used to control the copy number of a biological entity during amplification. In certain cases, biological entities with different amplification rates can be amplified independently of each other. In some embodiments, the ratio of a rapidly amplifying biological entity to a slowly amplifying biological entity can be controlled. This can be advantageous, for example, in preserving diversity within a library by preventing rapidly amplifying biological entities from outcompeting slowly amplifying biological entities. For example, certain methods and systems of the invention can be useful in situations where preferential amplification of library members can present a problem.
    • 本发明通常涉及生物实体的扩增,例如用于噬菌体展示。 在一个方面,生物实体文库的成员被包封在分离的隔室中(例如,在单独的微流体液滴中)并被扩增。 作为具体实例,通过将噬菌体展示文库的成员置于微流体液滴中,使得没有液滴包含多于一个文库的成员,可以扩增文库,而不会在生长速率或群体分布或由其产生的其他伪影中产生任何实质性变化 图书馆不同成员之间的增长速度差异或差异。 在一些情况下,隔室的体积可以用于在放大期间控制生物实体的拷贝数。 在某些情况下,具有不同扩增率的生物实体可以彼此独立地扩增。 在一些实施方案中,可以控制快速扩增的生物实体与缓慢扩增的生物实体的比例。 这可能是有利的,例如,通过防止快速扩增生物实体免于超过慢性扩增的生物实体来保存文库内的多样性。 例如,本发明的某些方法和系统可用于库成员的优先扩增可能存在问题的情况。